Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | monoglyceride lipase | References | |
Homo sapiens | fatty acid amide hydrolase | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | fatty acid amide hydrolase | 579 aa | 471 aa | 26.5 % |
Plasmodium falciparum | esterase, putative | monoglyceride lipase | 303 aa | 254 aa | 19.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | PST-A protein | 0.0168 | 1 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0168 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0168 | 1 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0168 | 1 | 1 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0123 | 0.7046 | 1 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0123 | 0.7046 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0168 | 1 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0123 | 0.7046 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0168 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 1 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0123 | 0.7046 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0168 | 1 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0168 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0168 | 1 | 1 |
Plasmodium falciparum | esterase, putative | 0.0168 | 1 | 1 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0168 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0168 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 1 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0168 | 1 | 1 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0015 | 0 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 1 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0168 | 1 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0123 | 0.7046 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0168 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.7046 | 1 |
Mycobacterium ulcerans | lysophospholipase | 0.0168 | 1 | 1 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0015 | 0 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 1 | 0.5 |
Schistosoma mansoni | amidase | 0.0123 | 0.7046 | 1 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0168 | 1 | 0.5 |
Brugia malayi | amidase | 0.0123 | 0.7046 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 31.2 nM | Inhibition of recombinant C-terminal His6-tagged human MAGL expressed in Escherichia coli using 2-arachidonoyl-[3H]-glycerol as substrate incubated for 20 mins by scintillation counting method | ChEMBL. | 26888301 |
IC50 (binding) | = 728.5 nM | Inhibition of recombinant C-terminal His6-tagged human MAGL expressed in Escherichia coli using 2-arachidonoyl-[3H]-glycerol as substrate preincubated for 10 mins followed by substrate addition measured after 20 mins by scintillation counting method | ChEMBL. | 26888301 |
IC50 (binding) | = 7740 nM | Inhibition of recombinant C-terminal His-tagged human FAAH expressed in sf21 cells using N-arachidonoyl-[14C]-ethanolamine as substrate assessed as reduction in [14C]ethanolamine production incubated for 30 mins by scintillation counting method | ChEMBL. | 26888301 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.